Abstract
Aspirin-exacerbated respiratory disease (AERD) is characterized by asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and respiratory reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase-1. The syndrome occurs in about 7% of adults with asthma and 25-30% of adults with asthma and CRSwNP.1 AERD is primarily a disease of adult-onset and has a female predominance, with about a 2:1 female to male ratio of disease incidence.2 The prevalence of AERD in the pediatric population is not well defined, with only case reports or small series studies available.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Allergy and Clinical Immunology: In Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
